Biodesix, Inc.
BDSX
$16.66
$1.449.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.96M | -35.27M | -39.54M | -41.08M | -40.42M |
| Total Depreciation and Amortization | 5.65M | 5.67M | 5.73M | 5.82M | 5.79M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.69M | 5.99M | 6.51M | 6.90M | 8.17M |
| Change in Net Operating Assets | -4.21M | 334.00K | -852.00K | -1.58M | -15.48M |
| Cash from Operations | -24.84M | -23.27M | -28.15M | -29.94M | -41.94M |
| Capital Expenditure | -266.00K | -259.00K | -1.01M | -1.20M | -3.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -144.00K | -144.00K | -171.00K | -207.00K | -234.00K |
| Cash from Investing | -410.00K | -403.00K | -1.18M | -1.40M | -3.30M |
| Total Debt Issued | 10.00M | 10.00M | 10.00M | 10.00M | -- |
| Total Debt Repaid | -19.00K | -21.00K | -29.00K | -38.00K | -45.00K |
| Issuance of Common Stock | 25.07M | 7.82M | 5.50M | 674.00K | 55.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.84M | -1.38M | -948.00K | -787.00K | -4.28M |
| Cash from Financing | 33.22M | 16.42M | 14.53M | 9.85M | 51.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.97M | -7.26M | -14.80M | -21.49M | 6.11M |